SEC Targets Teva In FCPA Compliance Probe

Law360, New York (August 3, 2012, 8:43 PM EDT) -- Teva Pharmaceutical Industries Ltd. has joined the growing list of pharmaceutical companies that have been subpoenaed by the U.S. Securities and Exchange Commission as part of an investigation into possible Foreign Corrupt Practices Act violations abroad, the company said Thursday.

The Israel-based generic drug giant admitted in an SEC filing that it had received a subpoena from the SEC in July seeking documents related to its FCPA compliance in Latin America. In the filing, the company said that it was cooperating with the government and that...
To view the full article, register now.